Viant Technology DSP
- Market cap
- $918M
- PE
- n/m
- one or more of the four quarters through 2026-06-30 missing
- Forward PE
- n/m
- not a meaningful number
- Price to sales
- 2.4×
- EV/EBIT
- 102×
- Revenue, 12 months
- $388.5M
- +22% on a year ago
- Net margin
- 2.2%
- Free cash flow yield
- 7.2%
Viant Technology trades at 2.4× sales. Revenue was $388.5M over the last twelve months, up 22% on a year earlier with a 2% net margin.
Charts
Financials
| Income statement | Q3 FY23 | Q4 FY23 | Q1 FY24 | Q2 FY24 | Q3 FY24 | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $59.6M+22% | $64.4M+18% | $53.4M+28% | $65.9M+15% | $79.9M+34% | $90.1M+40% | $70.6M+32% | $77.9M+18% | $85.6M+7% | $110.1M+22% | $88.5M+25% | $104.3M+34% | |
| Cost of revenue | $31M+13% | $32.7M+2% | $29.9M+28% | $35.1M+5% | $44.6M+44% | $47.6M+46% | $40.1M+34% | $42M+20% | $45.7M+3% | $58.8M+24% | $52.2M+30% | $58.7M+40% |
| Gross profit | $28.6M+34% | $31.8M+41% | $23.5M+28% | $30.7M+30% | $35.3M+23% | $42.5M+34% | $30.6M+30% | $35.9M+17% | $39.8M+13% | $51.3M+21% | $36.4M+19% | $45.5M+27% |
| SG&A | $25.3M−12% | $24.3M−6% | $24M+2% | $25.7M+13% | $25.7M+2% | $29.5M+21% | $28.5M+19% | $28.2M+10% | $27.9M+9% | $30.4M+3% | $33.2M+16% | $38.6M+37% |
| −$2.8M−78% | $882K | −$5.7M−49% | −$771K−85% | $4M | $5.9M+569% | −$4.9M−15% | $12K | $4.2M+5% | $12.7M+115% | −$4M−19% | −$3.9M | |
| Interest expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Pre-tax income | −$491K−96% | $3.3M | −$3.3M−65% | $1.6M | $6.4M | $8M+144% | −$3.5M+4% | $1.5M−6% | $5.7M−12% | $6.4M−20% | −$2.6M−25% | −$2.6M |
| $181K | −$30K | −$99K | $99K | −$14K | $263K | −$153K+55% | −$291K | $541K | −$14.1M | −$406K+165% | −$762K+162% | |
| Net income | −$526K−83% | $627K | −$947K−62% | $55K | $1.5M | $1.7M+179% | −$1.2M+26% | $290K+427% | $996K−34% | $8.3M+373% | −$455K−62% | −$111K |
| −$0.03−86% | $0.04 | −$0.06−65% | $0.00 | $0.09 | $0.09+125% | −$0.07+17% | $0.02 | $0.06−33% | n/a | −$0.03−57% | −$0.03 | |
| 15.4M+8% | 15.6M+8% | 15.9M+8% | 19.2M+27% | 20M+30% | 20.4M+31% | 16.4M+3% | 19.9M+4% | 19.2M−4% | n/a | 63.5M+286% | 65.2M+228% |
Gross profit: 26 periods, Q1 FY20 to Q2 FY26: not printed by the filing, worked out from its own lines.
EPS, diluted: 5 periods, Q4 FY20 to Q4 FY24: quarter's net income to common over its shares, to the cent.
Diluted shares: 3 periods, Q4 FY20 to Q4 FY23: share-days: the 12-month average less the 9-month, weighted by days. Q4 FY22: a loss quarter: its basic count, share-days: the 12-month average less the 9-month, weighted by days. Q4 FY24: the earlier year to date counted no dilution: the quarter's basic count plus the later year to date's dilution.
From each company's 10-Q and 10-K filings, the newest version of each figure. Quarters are as filed (a fourth quarter is the year less its first nine months), fiscal years as the 10-K prints them, restated where a later 10-K restated them, and balance sheet lines as of the period's end. A quarter whose 10-Q isn't filed yet is from the company's results release. Growth is on the same period a year earlier. A dash is a period with no figure for the line: the filing doesn't print it, or it hasn't been read yet.
Peers
Companies in Software - Application nearest Viant Technology's size, closest first.
| Company | Market cap | PE | Its 10y median PE | Fwd PE | P/S | Revenue growth | Net margin |
|---|---|---|---|---|---|---|---|
| DSPViant Technology | $918M | n/m | 116× | 2.4× | +22% | 2.2% | |
| HSTMHealthstream | $1B | 48.8× | 54.3× | 3.2× | +9% | 6.6% | |
| EVEREverQuote | $801.4M | 7.4× | 18.5× | 1.1× | +23% | 15.2% | |
| TASKTaskUs | $784.8M | 7.4× | 26.3× | 0.6× | +11% | 8.8% | |
| YEXTYext | $727.5M | 38.7× | 48.3× | 1.6× | −1% | 5.9% | |
| MNTNMNTN | $724.1M | 12.9× | 15.1× | 2.3× | +21% | 18.0% | |
| UPWKUpwork | $1.2B | 12.5× | 15.9× | 1.5× | +2% | 12.9% | |
| LZLegalzoom.Com | $1.2B | 77.7× | 68.5× | 1.5× | +12% | 2.1% | |
| NRDSNerdwallet | $698.7M | 12.3× | 15.9× | 0.8× | +12% | 7.6% | |
| GDRXGoodRx | $1.2B | 88.5× | 55.6× | 1.5× | −2% | 2.1% | |
| IBEXIBEX | $627.1M | 15.1× | 11.5× | 1.0× | +15% | 7.2% | |
| Peer median | $793.1M | 14.0× | 22.4× | 1.5× | +11% | 7.4% |
More on Viant Technology
Each number over time
- PE ratio
- Price to sales ratio
- EV/EBIT
- Price to free cash flow
- Price to book ratio
- Market cap
- Revenue
- EPS
- Free cash flow
- Profit margin
- Shares outstanding
Its groups
About
- Industry
- Software - Application
- Sector
- Technology
Valuation data, not investment advice. Prices as of .